Related Experiment Videos
General practitioner screening for melanoma: sensitivity, specificity, and effect of training
R C Burton1, C Howe, L Adamson
1Anti-Cancer Council of Victoria, Carlton, Australia.
Journal of Medical Screening
|October 31, 1998
Summary
General practitioners (GPs) showed high sensitivity in screening older adults for melanoma, but training did not significantly improve detection rates. Melanoma screening by GPs proved cost-effective, comparable to cervical cancer screening.
Area of Science:
- Dermatology
- Oncology
- Public Health
Background:
- Melanoma is a significant health concern, particularly in older populations.
- Effective screening strategies are crucial for early detection and improved patient outcomes.
Purpose of the Study:
- To evaluate the performance of trained and untrained general practitioners (GPs) in screening individuals aged 50 and above for melanoma.
- To assess the impact of specific melanoma diagnostic training on GP performance.
Main Methods:
- General practitioners (GPs), both trained and untrained in melanoma diagnosis, alongside skin cancer specialists, examined volunteers.
- Volunteers included individuals with pre-diagnosed suspicious pigmented lesions (SPLs) for histopathological analysis.
Main Results:
- Trained and untrained GPs demonstrated similar sensitivities (0.73 vs. 0.71) and predictive values (0.40 vs. 0.37) for detecting pre-diagnosed SPLs.
- Post-histopathology analysis showed high sensitivities (0.98 vs. 0.95) for both groups in identifying melanoma, but with low specificities (0.52 vs. 0.49) and positive predictive values (0.24 vs. 0.22).
- Trained GPs showed a statistically significant improvement in diagnosing melanomas (p=0.04).
Conclusions:
- GPs achieve high sensitivity in melanoma screening for older adults, though this is accompanied by low specificity and positive predictive values.
- Melanoma diagnostic training did not significantly enhance screening performance in terms of sensitivity, specificity, or positive predictive value.
- Population screening models indicate that GP-led melanoma screening is cost-effective, comparable to cervical cancer screening.